Genentech, Inc. (NYSE: DNA) said a Special Committee of its Board of Directors unanimously recommended that shareholders reject ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE